Adenovirus-mediated p53 gene therapy and paclitaxel have synergistic efficacy in models of human head and neck, ovarian, prostate, and breast cancer.
Clinical cancer research: an official journal of the …, 1998 - AACR
Synergy (or antagonism) between two chemical agents is an in vitro empirical phenomenon,
in which the observed effect of the combination is more (or less) than what would be …
in which the observed effect of the combination is more (or less) than what would be …
Adenovirus-mediated p53 gene therapy and paclitaxel have synergistic efficacy in models of human head and neck, ovarian, prostate, and breast cancer
LL Nielsen, P Lipari, J Dell… - … cancer research: an …, 1998 - pubmed.ncbi.nlm.nih.gov
Synergy (or antagonism) between two chemical agents is an in vitro empirical phenomenon,
in which the observed effect of the combination is more (or less) than what would be …
in which the observed effect of the combination is more (or less) than what would be …
Adenovirus-mediated p53 gene therapy and paclitaxel have synergistic efficacy in models of human head and neck, ovarian, prostate, and breast cancer.
LL Nielsen, P Lipari, J Dell, M Gurnani… - … Cancer Research: an …, 1998 - europepmc.org
Synergy (or antagonism) between two chemical agents is an in vitro empirical phenomenon,
in which the observed effect of the combination is more (or less) than what would be …
in which the observed effect of the combination is more (or less) than what would be …
[引用][C] Adenovirus-mediated p53 gene therapy and paclitaxel have synergistic efficacy in models of human head and neck, ovarian prostate, and breast cancer
N LL - Clin Cancer Res, 1998 - cir.nii.ac.jp
Adenovirus-mediated p53 gene therapy and paclitaxel have synergistic efficacy in models of
human head and neck, ovarian prostate, and breast cancer | CiNii Research CiNii 国立情報学 …
human head and neck, ovarian prostate, and breast cancer | CiNii Research CiNii 国立情報学 …
[引用][C] Adenovirus-mediated p53 gene therapy and paclitaxel have synergistic efficacy in models of human head and neck, ovarian, prostate, and breast cancer
LL NIELSEN, P LIPARI, J DELL… - Clinical cancer …, 1998 - pascal-francis.inist.fr
Adenovirus-mediated p53 gene therapy and paclitaxel have synergistic efficacy in models of human
head and neck, ovarian, prostate, and breast cancer CNRS Inist Pascal-Francis CNRS Pascal and …
head and neck, ovarian, prostate, and breast cancer CNRS Inist Pascal-Francis CNRS Pascal and …